Immunotherapies Stocks List

Recent Signals

Date Stock Signal Type
2021-04-20 ADAG Slingshot Bearish Bearish Swing Setup
2021-04-20 ADAG Pocket Pivot Bullish Swing Setup
2021-04-20 ADXS Narrow Range Bar Range Contraction
2021-04-20 ADXS Lower Bollinger Band Walk Weakness
2021-04-20 ADXS NR7 Range Contraction
2021-04-20 ADXS NR7-2 Range Contraction
2021-04-20 ALPN Bollinger Band Squeeze Range Contraction
2021-04-20 ALPN 20 DMA Support Bullish
2021-04-20 ALPN 200 DMA Support Bullish
2021-04-20 ALPN Hammer Candlestick Bullish
2021-04-20 ALPN Doji - Bullish? Reversal
2021-04-20 BLCM Lower Bollinger Band Walk Weakness
2021-04-20 BLCM 180 Bearish Setup Bearish Swing Setup
2021-04-20 CMPI NR7 Range Contraction
2021-04-20 CMPI New 52 Week Closing Low Bearish
2021-04-20 CMPI Lizard Bullish Bullish Day Trade Setup
2021-04-20 CMPI Doji - Bullish? Reversal
2021-04-20 CMPI Hammer Candlestick Bullish
2021-04-20 CMPI Narrow Range Bar Range Contraction
2021-04-20 CMPI New 52 Week Low Weakness
2021-04-20 GMAB Upper Bollinger Band Walk Strength
2021-04-20 GOVX NR7 Range Contraction
2021-04-20 GOVX Narrow Range Bar Range Contraction
2021-04-20 IMCR NR7 Range Contraction
2021-04-20 IMTX 20 DMA Support Bullish
2021-04-20 IMTX Narrow Range Bar Range Contraction
2021-04-20 IMTX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-04-20 IMTX NR7 Range Contraction
2021-04-20 MRKR Fell Below 200 DMA Bearish
2021-04-20 NBTX 20 DMA Resistance Bearish
2021-04-20 NEXI Stochastic Reached Oversold Weakness
2021-04-20 ONCR NR7 Range Contraction
2021-04-20 ONCR Bollinger Band Squeeze Range Contraction
2021-04-20 PDSB 50 DMA Support Bullish
2021-04-20 PDSB MACD Bearish Signal Line Cross Bearish
2021-04-20 PDSB Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-04-20 PDSB 20 DMA Support Bullish
2021-04-20 RCUS NR7 Range Contraction
2021-04-20 RCUS 20 DMA Support Bullish
2021-04-20 RCUS Spinning Top Other
2021-04-20 SURF New Downtrend Bearish
2021-04-20 SURF Lower Bollinger Band Walk Weakness
2021-04-20 SURF Doji - Bullish? Reversal

Recent News for Immunotherapies Stocks

Date Stock Title
Apr 21 CMPI The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue
Apr 21 NEXI NexImmune Appoints Chad Rubin as Senior Vice President, Corporate Affairs
Apr 20 ADXS ADVAXIS MAKING BOLD STEPS IN NEW CANCER STUDIES AND AGREEMENT WITH COLUMBIA UNIVERSITY
Apr 20 GOVX 10 Best Biotech Stocks Under $6 in 2021
Apr 20 EVAX Evaxion Biotech Presents Paper on Potential of Deep Data on Immune Complex Stability to Optimize Cancer Immunotherapy
Apr 20 GMAB Genmab Q1 Darzalex sales reached 1,365M
Apr 20 GMAB Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2021
Apr 20 AFMD Affimed's Novel Immune Engineering Approach In Oncology
Apr 19 PDSB PDS Biotech Announces Participation in Noble Capital Markets Virtual Road Show Series
Apr 19 ONCR Biogen seen to offer a ‘compelling’ risk-reward profile, TG Therapeutics price target lifted after MS data; and more in today’s analyst action
Apr 19 SURF Surface Oncology Named a 2021 Best Places to Work Company by Boston Business Journal
Apr 19 CMPI Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Phase 2 Head and Neck Cancer Trial
Apr 18 AFMD Affimed: Wholly-Owned Pipeline Programs Support A Long-Term Investment
Apr 18 AFMD AACR 2021 highlights Eli Lilly’s new KRAS battle; Affimed’s Natural Killer cell therapy
Apr 16 ALPN Is the Options Market Predicting a Spike in Alpine (ALPN) Stock?
Apr 16 CMPI Here's Why We're Watching Checkmate Pharmaceuticals' (NASDAQ:CMPI) Cash Burn Situation
Apr 15 ALPN Alpine Immune Sciences Is A Blind Buy After The Recent Price Decrease
Apr 15 AFMD Why Affimed N.V. Stock Dropped Today
Apr 15 AFMD Affimed N.V. (AFMD) CEO Adi Hoess on Q4 2020 Results - Earnings Call Transcript
Apr 15 AFMD ‘Natural Killer Cells’ and Other Promising Cancer Treatments

Immunotherapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.

In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer.Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease.Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells.
Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. Others including IL-2, IL-7, IL-12, various chemokines, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.

More about Immunotherapies
Browse All Tags